DiaMedica Therapeutics - 48 Year Dividend History | DMAC

Historical dividend payout and yield for DiaMedica Therapeutics (DMAC) since 1971. The current TTM dividend payout for DiaMedica Therapeutics (DMAC) as of April 24, 2019 is $0.00. The current dividend yield for DiaMedica Therapeutics as of April 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.040B $0.001B
DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.723B 12.48
Gilead Sciences (GILD) United States $80.369B 10.23
Bio-Techne Corp (TECH) United States $7.248B 48.83